profit from every $100 of sales.
$0$100
Simulations Plus
We have no price for Simulations Plus since 7 October 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$18.50+0.00% today
+19.9% in 1 year
1-year low $11.361-year high $20.84
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Simulations Plus sold, what it kept, and what it did with the cash.
Sales went from $53.9 million in 2022 to $79.2 million in 2025, with -$64.7 million of profit last year.
SalesProfit
Simulations Plus vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Simulations Plus | No profit yet | ||
 GE HealthCare Technologies | 18.0× · Fair price | ||
 BrightSpring Health Services | 74.3× · Very expensive | ||
 Tempus AI | No profit yet | ||
 HealthEquity | 39.8× · Expensive |
AI analysis
An AI analyst reads Simulations Plus's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 54 | 60 | 70 | 79 | |
| 43 | 48 | 43 | 46 | |
| 15 | 9 | 6 | 6 | |
| 18 | 13 | 12 | 15 | |
| 12 | 10 | 10 | -65 | |
| 0.60 | 0.49 | 0.49 | -3.22 | |
| 79.9% | 80.5% | 61.6% | 58.4% | |
| 27.7% | 15.5% | 8.8% | 8.2% | |
| 23.2% | 16.7% | 14.2% | -81.7% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 188 | 186 | 197 | 132 |
| Cash | 52 | 58 | 10 | 31 |
| Total debt | 1 | 1 | 1 | 1 |
| Total liabilities | 10 | 16 | 14 | 7 |
| 178 | 170 | 182 | 125 | |
| 21 | 20 | 20 | 20 | |
| 6.6% | 4.3% | 2.6% | 4.1% | |
| 7.0% | 5.9% | 5.5% | -51.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 18 | 22 | 13 | 18 | |
| 4 | 4 | 4 | 4 | |
| 14 | 18 | 9 | 14 | |
| Dividends paid | 5 | 5 | 5 | 0 |
| 0 | 20 | 0 | 0 | |
| 3 | 5 | 7 | 6 |
Valuation
- –
- –
- –
- 2.1×
- 4.7×
- 26.0×
- 23.4×
- 3.8%
- -17.3%
- 0.0%
Profitability
- 58.4%
- 8.2%
- -81.7%
- 20.9%
- -47.4%
- -5.5%
- -49.3%
- -42.9%
- -50.1%
- 11.6%
Growth
- +13.7%
- –
- +36.5%
- −5.6%
- +0.1%
Financial health
- -1.5×
- 0.00
- 0.3%
- –
- 5.47
- 5.47
- 0.55
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 6%of 963
Bottom 43%of 894
Top 41%of 908
Top 30%of 991
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 9, 2026 | 0.35 | 0.27 | +29.6% |
| Jan 8, 2026 | 0.13 | 0.18 | −27.8% |
| Dec 1, 2025 | 0.10 | 0.10 | +0.0% |
| Jul 14, 2025 | 0.45 | 0.26 | +73.1% |
| Apr 3, 2025 | 0.31 | 0.25 | +24.0% |
| Jan 7, 2025 | 0.17 | 0.18 | −5.6% |
| Oct 23, 2024 | 0.06 | 0.07 | −9.1% |
| Jul 2, 2024 | 0.15 | 0.15 | +0.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
36No pass
Benjamin Graham
52No pass
Philip Fisher
43No pass
Peter Lynch
52No pass
Joel Greenblatt
0No pass
Charlie Munger
36No pass
Terry Smith
31No pass
Questions about Simulations Plus
Is Simulations Plus a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Simulations Plus AI analysis
What does Simulations Plus do?
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It is in Medical - Healthcare Information Services.
Does Simulations Plus pay a dividend?
No. Simulations Plus does not pay a dividend at the moment.
Is Simulations Plus stock halal?
Yes. Simulations Plus passes our halal screen: its business is permitted and its debt is 0.2% of its market value, under the 30% limit. How we check
How has Simulations Plus stock done over the past year?
Up 19.9% over the past twelve months, to $18.50. It traded between $11.36 and $20.84 and is 11.2% below its high.
Who are Simulations Plus's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, BrightSpring Health Services, Tempus AI and HealthEquity. The peers table on this page compares their profit, growth and price with Simulations Plus's.
Prices: daily closes to Oct 7, 2026. Fundamentals: company reports via invest-like data.